PRGO

#2148
PERRIGO COMPANY PLC
11.4450 USD
+1.77%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
11.4050
11.4691
年范围
9.2250
22.0100
日变化
+1.77%
每月变动
+21.05%
6个月变化
-46.82%
年变化
-46.82%
前一天收盘价
11.2460
开盘价
11.4650
买价
卖价
最低价
11.4050
High
11.4691
交易量
264
展开完整图表

Financials

概览 声明 统计 股息
每季度 年度
  • Market Capitalization 1.5754 B
  • Employee 8 100
  • Founded N/A
  • CEO Murray S. Kessler
  • Website www.perrigo.com
  • Headquarter Ireland
  • FIGI N/A
  • Industry Technology
总收入
净利润
每股基本收益（基本 EPS）
总债务
自由现金流
现金及现金等价物
市盈率
-1.35
市销率
0.45
每股股息
1.16
股息收益率 %
8.33

Perrigo Company plc

Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters in Grand Rapids, Michigan, within Michigan State University's Grand Rapids Innovation Park. Perrigo engages in the acquisition, manufacture, and sale of consumer healthcare products, generic prescription drugs, and active pharmaceutical ingredients, primarily in the United States, from its base in Ireland. On 21 December 2018, Perrigo suffered its biggest one-day share price fall in its history after the Irish Revenue Commissioners issued a tax claim against Perrigo that equated to half of its market value.

新闻